Regeneron Pharmaceuticals, Inc.REGNNASDAQ
Loading
PB Ratio: Discounted ValuationCompressed
Percentile Rank0
3Y CAGR-8.8%
5Y CAGR-11.3%
Year-over-Year Change
Price-to-book ratio
3Y CAGR
-8.8%/yr
vs -8.7%/yr prior
5Y CAGR
-11.3%/yr
Consistent
Acceleration
-0.2pp
Decelerating
Percentile
P0
Near historical low
vs 5Y Ago
0.5x
Contraction
Streak
2 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 2.58 | -1.4% |
| 2024 | 2.62 | -27.4% |
| 2023 | 3.61 | +5.8% |
| 2022 | 3.41 | -4.1% |
| 2021 | 3.56 | -24.6% |
| 2020 | 4.71 | +27.5% |
| 2019 | 3.70 | -24.5% |
| 2018 | 4.90 | -31.0% |
| 2017 | 7.09 | -26.1% |
| 2016 | 9.59 | - |